ACR appropriateness criteria palpable breast masses
- PMID: 24091044
- DOI: 10.1016/j.jacr.2013.06.013
ACR appropriateness criteria palpable breast masses
Abstract
A palpable breast mass is one of the most common presenting features of breast carcinoma. However, the clinical features are frequently nonspecific. Imaging performed before biopsy is helpful in characterizing the nature of the mass. For women with clinically detected breast masses, the vast majority will require evaluation with ultrasound. Diagnostic mammography is the initial imaging modality of choice for women aged ≥ 40 years; ultrasound is typically necessary unless a definitively benign mass is identified as the etiology of the clinical finding. For evaluating women aged <30 years and women who are pregnant or lactating, ultrasound is used for initial evaluation. For women aged 30 to 39 years, either ultrasound or diagnostic mammography may be used for initial evaluation. MRI is rarely indicated to evaluate a clinically detected finding. Biopsy is indicated for masses with suspicious features. Short-term follow-up is a reasonable alternative to biopsy for solid masses with probably benign features suggesting fibroadenoma. Correlation between imaging and the clinical finding is essential. The ACR Appropriateness Criteria(®) are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Keywords: Appropriateness criteria; breast mass; breast self-examination; breast ultrasound; clinical breast examination; mammography.
Copyright © 2013 American College of Radiology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
ACR Appropriateness Criteria Palpable Breast Masses.J Am Coll Radiol. 2016 Nov;13(11S):e31-e42. doi: 10.1016/j.jacr.2016.09.022. J Am Coll Radiol. 2016. PMID: 27814822 Review.
-
ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update.J Am Coll Radiol. 2023 May;20(5S):S146-S163. doi: 10.1016/j.jacr.2023.02.013. J Am Coll Radiol. 2023. PMID: 37236740 Review.
-
ACR Appropriateness Criteria® Palpable Breast Masses.J Am Coll Radiol. 2017 May;14(5S):S203-S224. doi: 10.1016/j.jacr.2017.02.033. J Am Coll Radiol. 2017. PMID: 28473077 Review.
-
ACR Appropriateness Criteria stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women.J Am Coll Radiol. 2014 Dec;11(12 Pt A):1160-8. doi: 10.1016/j.jacr.2014.08.020. Epub 2014 Oct 23. J Am Coll Radiol. 2014. PMID: 25444069
-
ACR Appropriateness Criteria® Stage I Breast Carcinoma.J Am Coll Radiol. 2016 Nov;13(11S):e53-e57. doi: 10.1016/j.jacr.2016.09.024. J Am Coll Radiol. 2016. PMID: 27814824 Review.
Cited by
-
Positive association between progestins and the evolution of multiple fibroadenomas in 72 women.Endocr Connect. 2020 Jun;9(6):570-577. doi: 10.1530/EC-20-0012. Endocr Connect. 2020. PMID: 32485673 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
